NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

New Perspectives on Antimicrobial Agents: Remdesivir Treatment for

NIH funds study to evaluate remdesivir for COVID-19 in pregnancy

Therapeutic Management of Nonhospitalized Adults With COVID-19

Efficacy Data for COVID-19

The Incidence, Severity, and Management of COVID-19 in Critically

VEKLURY® (remdesivir) Educational Videos

Global interim guidance on coronavirus disease 2019 (COVID‐19

COVID-19 and Pregnancy: Risks and Outcomes - Nursing for Women's

Relationship of COVID-19 with pregnancy - ScienceDirect

Policy Actions for the US Government to Accelerate Access to Oral

Management of Patients With COVID-19

Remdesivir for the treatment of hospitalized patients with severe